Danny Bar-Zohar, Merck KGaA healthcare CMO
Merck KGaA spotlights need for deals to shake up R&D, with external partners key to new drugs
German healthcare company Merck KGaA wants to ramp up its R&D productivity with the goal of launching a new drug, or tacking on a new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
